I agree that this site is using cookies. You can find further informations here.
X
Martinez-Jañez, Noelia
99  results:
Search for persons X
?
1

Single-agent metronomic versus weekly oral vinorelbine as f..:

Freyer, Gilles ; Martinez-Jañez, Noelia ; Kukielka-Budny, Bożena...
The Breast.  74 (2024)  - p. 103681 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Quality of life with palbociclib plus fulvestrant versus pl..:

Tibau, Ariadna ; Martínez, M. Teresa ; Ramos, Manuel...
Therapeutic Advances in Medical Oncology.  15 (2023)  - p. 175883592211489 , 2023
Link: https://doi.org/10.1177/..
 
?
3

Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 V..:

Saavedra, Cristina ; Vallejo, Alejandro ; Longo, Federico...
Cancers.  15 (2023)  7 - p. 2000 , 2023
Link: https://doi.org/10.3390/..
 
?
4

Evaluation of ERBB2 mRNA Expression in HER2-Equivocal (2+) ..:

Carretero-Barrio, Irene ; Caniego-Casas, Tamara ; Rosas, Marta...
Cancers.  15 (2023)  6 - p. 1688 , 2023
Link: https://doi.org/10.3390/..
 
?
5

Sapanisertib plus Fulvestrant in Postmenopausal Women with ..:

García-Sáenz, José Á. ; Martínez-Jáñez, Noelia ; Cubedo, Ricardo...
Clinical Cancer Research.  28 (2022)  6 - p. 1107-1116 , 2022
Link: https://doi.org/10.1158/..
 
?
6

Long-Term Cardiac Safety and Survival Outcomes of Neoadjuva..:

Gil-Gil, Miguel J. ; Bellet, Meritxell ; Bergamino, Milana...
Frontiers in Oncology.  11 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
7

Safety of eribulin as third-line chemotherapy in HER2-negat..:

Manso, Luis ; Moreno Antón, Fernando ; Izarzugaza Perón, Yann...
The Breast Journal.  25 (2019)  2 - p. 219-225 , 2019
Link: https://doi.org/10.1111/..
 
?
8

Phase III evaluating the addition of fulvestrant (F) to ana..:

Ruíz-Borrego, Manuel ; Guerrero-Zotano, Angel ; Bermejo, Begoña...
Breast Cancer Research and Treatment.  177 (2019)  1 - p. 115-125 , 2019
Link: https://doi.org/10.1007/..
 
?
9

Broad consensus on the optimal sequence for the systemic tr..:

Sánchez-Rovira, Pedro ; Zamora, Pilar ; Salvador-Bofill, Javier...
Journal of Drug Assessment.  8 (2019)  1 - p. 62-69 , 2019
Link: https://doi.org/10.1080/..
 
?
10

A Pilot, Phase II, Randomized, Open-Label Clinical Trial Co..:

Ciruelos, Eva ; Apellániz-Ruiz, María ; Cantos, Blanca...
The Oncologist.  24 (2019)  11 - p. e1024-e1033 , 2019
Link: https://doi.org/10.1634/..
 
?
11

Increased expression of MNK1b, the spliced isoform of MNK1,..:

Pinto-Díez, Celia ; García-Recio, Eva M. ; Pérez-Morgado, M. Isabel...
Oncotarget.  9 (2018)  17 - p. 13501-13516 , 2018
Link: https://doi.org/10.18632..
 
?
12

Pleomorphic lobular carcinoma of the breast with osteoclast..:

Peña-Jaimes, Lourdes ; González-García, Irene ; Reguero-Callejas, María Eugenia...
Diagnostic Pathology.  13 (2018)  1 - p. , 2018
Link: https://doi.org/10.1186/..
 
?
13

Critically short telomeres and toxicity of chemotherapy in ..:

Quintela-Fandino, Miguel ; Soberon, Nora ; Lluch, Ana...
Oncotarget.  8 (2017)  13 - p. 21472-21482 , 2017
Link: https://doi.org/10.18632..
 
?
14

Maintained complete response to talazoparib in a BRCA-2 mut..:

Albarrán, Víctor ; Chamorro, Jesús ; Pozas, Javier...
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
15

Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 V..:

Saavedra, Cristina ; Vallejo, Alejandro ; Longo, Federico...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093435/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
1-15